A key sub-group from a provincial cohort of individuals impacted substance use disorder in BC. The project was developed to monitor service use, health care integration and patient outcomes in BC on a continuing basis and to provide the foundation for evaluative studies on the costs and benefits of the DTES-2GS.
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
